ELMD (Electromed) EPS without NRI: $1.17 (TTM As of Mar. 2026)


ELMD Electromed Inc ELMD
85 GF Score
Price $46.45
GF Value $25.25
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Electromed EPS without NRI?

Electromed ELMD +2.25% 85 EPS without NRI is $1.17 as of Mar. 2026. GuruFocus rates ELMD with a GF Score™ of 85/100 and a GF Value™ of $25.25 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 664 Medical Devices & Instruments companies, Electromed ranks better than 88.1% on this metric.

Electromed's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $0.35. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $1.17.

During the past 12 months, Electromed's average earnings per share (NRI) Growth Rate was 48.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 48.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 17.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Electromed's EPS without NRI or its related term are showing as below:

ELMD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -55   Med: 17.3   Max: 86.6
Current: 48.4

During the past 13 years, Electromed's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 86.60% per year. The lowest was -55.00% per year. And the median was 17.30% per year.

ELMD's 3-Year EPS without NRI Growth Rate is ranked better than
88.1% of 664 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs ELMD: 48.40

Electromed's EPS (Diluted) for the three months ended in Mar. 2026 was $0.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $1.17.

Electromed's EPS (Basic) for the three months ended in Mar. 2026 was $0.37. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $1.22.


Electromed  (AMEX:ELMD) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Electromed EPS without NRI Related Terms


Electromed EPS without NRI Historical Data

* Premium members only.

The historical data trend for Electromed's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromed EPS without NRI Chart

Electromed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.26 0.36 0.58 0.85

Electromed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.25 0.25 0.32 0.35

ELMD vs CATX, MASS, CV: EPS without NRI Comparison

For the Medical Devices subindustry, Electromed's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromed PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromed's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Electromed's PE Ratio without NRI falls into.


ELMD
85GF Score
Electromed Inc ELMD
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Electromed EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $1.17 mean?
Electromed (ELMD) has a EPS without NRI of $1.17 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Electromed and its competitors. According to the industry distribution chart, Electromed ranks #79 out of 664 companies in the Medical Devices & Instruments industry, placing it in the top 11.9%.
Is Electromed's EPS without NRI too high?
Electromed's current EPS without NRI is $1.17. The Medical Devices & Instruments industry median EPS without NRI is 8.15. Electromed's value of $1.17 is 85.6% below this industry median. Based on the distribution chart, Electromed ranks #79 out of 664 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Electromed has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's EPS without NRI compare to CATX and MASS?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #79 out of 664 companies for EPS without NRI. This places Electromed in the top 12% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.15. Electromed's value of $1.17 is 85.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Electromed's current EPS without NRI of $1.17 is 85.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Electromed and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Electromed's current EPS without NRI is $1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.25, compared to a current price of $46.45 — trading 84% above its estimated fair value. The current EPS without NRI is $1.17 and 85.6% below the Medical Devices & Instruments industry median of 8.15. Electromed's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Electromed (ELMD), the current EPS without NRI is $1.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Electromed (ELMD) Overvalued in 2026?

Based on GuruFocus' analysis, Electromed stock appears to be overvalued. The current stock price of $46.45 is trading 84% above its estimated GF Value™ of $25.25. GuruFocus considers Electromed to be Significantly Overvalued.

Key valuation signals for ELMD:

  • EPS without NRI: $1.17
  • GF Value™: $25.25 vs. price of $46.45 (84% above fair value)
  • GF Score™: 85/100 with 5 warning signs
  • Industry Position: 85.6% below the Medical Devices & Instruments median (#79 of 664)

No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Electromed Business Description

Address 500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
85GF Score

Get the complete analysis for ELMD

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$46.45
Price
$25.25
GF Value